Dr. Lal Path Labs
2,774.00
-22.30(-0.80%)
Market Cap₹23,426.10 Cr
PE Ratio47.91
Company Performance:
1D-0.80%
1M+0.29%
6M-9.14%
1Y-1.75%
5Y+75.84%
View Company Insightsright
More news about Dr. Lal Path Labs
02Apr 25
Dr. Lal PathLabs Witnesses Substantial Block Trade on NSE
A significant block trade of Dr. Lal PathLabs Ltd. shares occurred on the National Stock Exchange (NSE). The transaction involved 593,348 shares at ₹2,406.50 per share, totaling ₹142.79 crore. This large-scale trade could potentially impact the company's short-term trading patterns and may indicate shifts in ownership or strategy among major investors.
05Mar 25
Dr. Lal PathLabs Sees Major Block Trade Worth ₹54.54 Crore on NSE
A significant block trade of approximately 227,175 shares of Dr. Lal PathLabs Ltd. occurred on the National Stock Exchange. The shares were traded at ₹2,400.75 each, totaling a transaction value of ₹54.54 crore. This large-scale trade has drawn market attention, potentially signaling shifts in institutional or large investor holdings.
27Feb 25
Dr. Lal Path Labs Witnesses Significant Block Trade on NSE
A significant block trade of 116,643 shares of Dr. Lal Path Labs Ltd. occurred on the NSE, valued at Rs. 27.26 crores. The average price per share was Rs. 2,336.95. This large transaction could potentially impact the stock's trading pattern in the short term.
Dr. Lal Path Labs
2,774.00
-22.30
(-0.80%)
1 Year Returns:-1.75%
Industry Peers
Dr. Lal Path Labs
2,774.00
(-0.80%)
Metropolis Healthcare
1,710.30
(+0.24%)
Krsnaa Diagnostics
701.10
(-0.58%)
Suraksha Diagnostic
328.90
(+1.14%)
3B BlackBio DX
1,469.95
(+1.09%)
Sastasundar Ventures
295.60
(-0.44%)
Choksi Laboratories
197.95
(+4.99%)